MESALAMINE

MESALAMINE was reported 28210 times

These side effects are most commonly reported by patients taking MESALAMINE:

# Side effect Count
0 OFF LABEL USE 9285
1 DRUG INEFFECTIVE 7291
2 COLITIS ULCERATIVE 6827
3 DIARRHOEA 5004
4 CONDITION AGGRAVATED 4701
5 FATIGUE 3923
6 ABDOMINAL PAIN 3788
7 HAEMATOCHEZIA 3734
8 NAUSEA 3373
9 HEADACHE 3200
10 PYREXIA 2999
11 ARTHRALGIA 2979
12 CROHN^S DISEASE 2886
13 WEIGHT DECREASED 2833
14 PAIN 2761
15 FREQUENT BOWEL MOVEMENTS 2572
16 MALAISE 2566
17 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2227
18 INTENTIONAL PRODUCT USE ISSUE 2141
19 VOMITING 2103
20 DYSPNOEA 1821
21 RECTAL HAEMORRHAGE 1798
22 RASH 1797
23 ASTHENIA 1796
24 DIZZINESS 1794
25 WEIGHT INCREASED 1777
26 PNEUMONIA 1608
27 INJECTION SITE PAIN 1604
28 NASOPHARYNGITIS 1554
29 PRURITUS 1394
30 PAIN IN EXTREMITY 1386
31 ABDOMINAL PAIN UPPER 1383
32 COVID-19 1318
33 PRODUCT USE ISSUE 1273
34 ANXIETY 1256
35 CONSTIPATION 1256
36 COLITIS 1242
37 ABDOMINAL DISCOMFORT 1233
38 COUGH 1225
39 HYPERTENSION 1200
40 DECREASED APPETITE 1185
41 INFUSION RELATED REACTION 1168
42 ALOPECIA 1123
43 ANAEMIA 1109
44 BLOOD PRESSURE INCREASED 1084
45 INCORRECT DOSE ADMINISTERED 1059
46 DEPRESSION 1028
47 BACK PAIN 1004
48 CHEST PAIN 1001
49 HYPERSENSITIVITY 1001
50 ABDOMINAL DISTENSION 996
51 SINUSITIS 975
52 STRESS 956
53 ARTHRITIS 951
54 MUSCLE SPASMS 947
55 HYPOAESTHESIA 938
56 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 926
57 DRUG HYPERSENSITIVITY 908
58 URTICARIA 905
59 INFECTION 890
60 INSOMNIA 863
61 PRODUCT USE IN UNAPPROVED INDICATION 855
62 DYSPEPSIA 846
63 ERYTHEMA 843
64 PRODUCT DOSE OMISSION ISSUE 834
65 MACULAR DEGENERATION 809
66 PERIPHERAL SWELLING 807
67 MIGRAINE 789
68 TREATMENT FAILURE 776
69 CONFUSIONAL STATE 757
70 OROPHARYNGEAL PAIN 757
71 FALL 745
72 PARAESTHESIA 735
73 OEDEMA PERIPHERAL 733
74 MYALGIA 729
75 DRUG INTOLERANCE 728
76 DEATH 725
77 JOINT SWELLING 724
78 MATERNAL EXPOSURE DURING PREGNANCY 719
79 ASTHMA 716
80 GASTROINTESTINAL DISORDER 716
81 DEHYDRATION 707
82 CLOSTRIDIUM DIFFICILE INFECTION 705
83 URINARY TRACT INFECTION 704
84 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 692
85 FLATULENCE 691
86 GAIT DISTURBANCE 685
87 MUSCULOSKELETAL STIFFNESS 685
88 GENERAL PHYSICAL HEALTH DETERIORATION 659
89 CHILLS 655
90 PANCREATITIS 654
91 SYSTEMIC LUPUS ERYTHEMATOSUS 645
92 FEELING ABNORMAL 638
93 CONTUSION 628
94 INFLUENZA 615
95 C-REACTIVE PROTEIN INCREASED 610
96 INFLAMMATION 608
97 CROHN'S DISEASE 602
98 HAEMOGLOBIN DECREASED 601
99 SOMNOLENCE 597
100 VISUAL IMPAIRMENT 597
101 MUCOUS STOOLS 596
102 DEFAECATION URGENCY 591
103 MUSCULAR WEAKNESS 590
104 PERICARDITIS 581
105 PSORIASIS 575
106 HAEMORRHAGE 569
107 HEPATIC ENZYME INCREASED 566
108 IMPAIRED HEALING 560
109 WHEEZING 555
110 INJECTION SITE ERYTHEMA 552
111 PULMONARY EMBOLISM 547
112 RHEUMATOID ARTHRITIS 543
113 DISCOMFORT 541
114 MEMORY IMPAIRMENT 536
115 THERAPY NON-RESPONDER 532
116 IRRITABLE BOWEL SYNDROME 527
117 BRONCHITIS 526
118 INTESTINAL OBSTRUCTION 524
119 WOUND 517
120 HYPERCHOLESTEROLAEMIA 515
121 NO ADVERSE EVENT 514
122 PALPITATIONS 510
123 MOBILITY DECREASED 507
124 OSTEOARTHRITIS 504
125 HEART RATE DECREASED 500
126 SWELLING 498
127 BLOOD PRESSURE FLUCTUATION 493
128 DRUG LEVEL DECREASED 491
129 THERAPEUTIC RESPONSE SHORTENED 488
130 HEART RATE INCREASED 487
131 LOWER RESPIRATORY TRACT INFECTION 485
132 UPPER RESPIRATORY TRACT INFECTION 481
133 TACHYCARDIA 479
134 ILLNESS 468
135 OSTEOPOROSIS 466
136 BLISTER 457
137 DRUG DOSE OMISSION 456
138 WOUND INFECTION 454
139 ARTHROPATHY 452
140 INJURY 451
141 OEDEMA 451
142 JOINT STIFFNESS 449
143 GASTROOESOPHAGEAL REFLUX DISEASE 448
144 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 447
145 INJECTION SITE HAEMORRHAGE 442
146 TYPE 2 DIABETES MELLITUS 437
147 DEEP VEIN THROMBOSIS 435
148 THERAPEUTIC REACTION TIME DECREASED 434
149 BLOOD CHOLESTEROL INCREASED 433
150 CEREBROVASCULAR ACCIDENT 433
151 DIARRHOEA HAEMORRHAGIC 428
152 EAR INFECTION 427
153 LUPUS-LIKE SYNDROME 424
154 TUBULOINTERSTITIAL NEPHRITIS 424
155 PROCTITIS 421
156 INFLUENZA LIKE ILLNESS 420
157 FEELING HOT 416
158 RHINORRHOEA 416
159 HYPOTENSION 415
160 ROAD TRAFFIC ACCIDENT 413
161 STOMATITIS 410
162 NEPHROLITHIASIS 409
163 NASAL CONGESTION 407
164 SEPSIS 407
165 TREMOR 407
166 FAECAL CALPROTECTIN INCREASED 406
167 INJECTION SITE BRUISING 405
168 SLEEP DISORDER 404
169 GLOSSODYNIA 401
170 LUNG DISORDER 399
171 ADVERSE DRUG REACTION 398
172 OVERDOSE 398
173 AMNESIA 397
174 FIBROMYALGIA 394
175 CHEST DISCOMFORT 387
176 PREGNANCY 387
177 FISTULA 386
178 DRUG LEVEL BELOW THERAPEUTIC 384
179 NIGHT SWEATS 382
180 PSORIATIC ARTHROPATHY 382
181 HEPATIC CIRRHOSIS 381
182 JOINT RANGE OF MOTION DECREASED 379
183 THERAPEUTIC PRODUCT EFFECT DECREASED 379
184 EXPOSURE DURING PREGNANCY 378
185 HELICOBACTER INFECTION 377
186 IMPAIRED QUALITY OF LIFE 377
187 FOLLICULITIS 374
188 DRY MOUTH 369
189 HYPERHIDROSIS 369
190 BRONCHIECTASIS 368
191 LIVER INJURY 367
192 HAND DEFORMITY 366
193 WHITE BLOOD CELL COUNT INCREASED 366
194 HOSPITALISATION 362
195 HAEMORRHOIDS 361
196 PROCEDURAL PAIN 361
197 JOINT DISLOCATION 360
198 LIVER DISORDER 360
199 VERTIGO 360
200 INJECTION SITE PRURITUS 354
201 PULMONARY FIBROSIS 348
202 RED BLOOD CELL SEDIMENTATION RATE INCREASED 346
203 ACUTE KIDNEY INJURY 344
204 ECZEMA 341
205 PEMPHIGUS 341
206 UNDERDOSE 341
207 AUTOIMMUNE DISORDER 340
208 LARYNGITIS 340
209 MUSCULOSKELETAL PAIN 339
210 PRODUCTIVE COUGH 339
211 SYNOVITIS 337
212 DRUG INTERACTION 336
213 MUSCLE INJURY 335
214 DRUG-INDUCED LIVER INJURY 333
215 GRIP STRENGTH DECREASED 333
216 RHEUMATIC FEVER 331
217 SCIATICA 331
218 HERPES ZOSTER 330
219 DELIRIUM 329
220 MEDICATION ERROR 328
221 INJECTION SITE SWELLING 326
222 IMPAIRED WORK ABILITY 325
223 EXOSTOSIS 322
224 LOWER LIMB FRACTURE 322
225 DUODENAL ULCER PERFORATION 320
226 ABDOMINAL PAIN LOWER 319
227 POOR VENOUS ACCESS 319
228 BLOOD PRESSURE DECREASED 318
229 DRUG SPECIFIC ANTIBODY PRESENT 317
230 TINNITUS 317
231 LOSS OF CONSCIOUSNESS 314
232 THROMBOSIS 313
233 FOOT DEFORMITY 312
234 PANCREATITIS ACUTE 312
235 RETINITIS 312
236 PRESCRIBED OVERDOSE 303
237 GASTROINTESTINAL INFLAMMATION 301
238 LUPUS VULGARIS 301
239 FLUSHING 298
240 PRODUCT AVAILABILITY ISSUE 297
241 ACNE 296
242 FAECES SOFT 296
243 SYNCOPE 295
244 ILL-DEFINED DISORDER 294
245 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 292
246 CELLULITIS 292
247 DISLOCATION OF VERTEBRA 292
248 GAIT INABILITY 292
249 INTERSTITIAL LUNG DISEASE 292
250 DYSGEUSIA 291
251 SWOLLEN JOINT COUNT INCREASED 291
252 DYSPHAGIA 286
253 DEEP VEIN THROMBOSIS POSTOPERATIVE 285
254 PRESCRIBED UNDERDOSE 285
255 VISION BLURRED 285
256 PARAESTHESIA ORAL 284
257 RASH PRURITIC 284
258 BONE EROSION 283
259 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 280
260 RHEUMATOID FACTOR POSITIVE 278
261 HIP ARTHROPLASTY 274
262 SWOLLEN TONGUE 273
263 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 272
264 CHRONIC SINUSITIS 272
265 LOSS OF THERAPEUTIC RESPONSE 269
266 KNEE ARTHROPLASTY 267
267 RENAL FAILURE 267
268 ANAL FISSURE 265
269 ORAL CANDIDIASIS 265
270 LIVER FUNCTION TEST INCREASED 261
271 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 261
272 FEMALE GENITAL TRACT FISTULA 260
273 ABSCESS 259
274 DEVICE ISSUE 258
275 SWELLING FACE 258
276 DIABETES MELLITUS 257
277 FOETAL EXPOSURE DURING PREGNANCY 254
278 GASTROINTESTINAL HAEMORRHAGE 253
279 PROCTALGIA 253
280 PRODUCT QUALITY ISSUE 253
281 CATARACT 248
282 VAGINAL DISCHARGE 247
283 ANAL FISTULA 246
284 NECK PAIN 245
285 ADVERSE EVENT 244
286 ANAL ABSCESS 240
287 ATRIAL FIBRILLATION 240
288 DIVERTICULITIS 240
289 DEVICE MALFUNCTION 238
290 BREAST CANCER STAGE III 237
291 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 237
292 THROMBOCYTOPENIA 236
293 RHINITIS 235
294 MYOCARDITIS 234
295 DRY SKIN 232
296 PANCYTOPENIA 232
297 CHRONIC KIDNEY DISEASE 230
298 HEART RATE IRREGULAR 230
299 RADICULOPATHY 229
300 STEROID DEPENDENCE 227
301 DRUG LEVEL ABOVE THERAPEUTIC 225
302 PLEURAL EFFUSION 222
303 DISEASE RECURRENCE 220
304 INFLAMMATORY BOWEL DISEASE 220
305 ACCIDENTAL OVERDOSE 219
306 ANAL INCONTINENCE 217
307 BURSITIS 216
308 THERAPEUTIC RESPONSE DECREASED 216
309 NIGHTMARE 215
310 RENAL IMPAIRMENT 215
311 VAGINAL FLATULENCE 215
312 WALKING AID USER 215
313 UNEVALUABLE EVENT 214
314 INJECTION SITE REACTION 213
315 MYOCARDIAL INFARCTION 211
316 JOINT INJURY 210
317 TRANSIENT ISCHAEMIC ATTACK 210
318 GINGIVAL PAIN 208
319 SMALL INTESTINAL OBSTRUCTION 208
320 C-REACTIVE PROTEIN ABNORMAL 206
321 WHITE BLOOD CELL COUNT DECREASED 206
322 CARDIAC MURMUR 205
323 FACET JOINT SYNDROME 203
324 HOT FLUSH 202
325 LARGE INTESTINE POLYP 200
326 INTENTIONAL PRODUCT MISUSE 198
327 BLOOD GLUCOSE INCREASED 197
328 LYMPHADENOPATHY 197
329 OXYGEN SATURATION DECREASED 197
330 PAROSMIA 197
331 BLOOD IRON DECREASED 196
332 LIP DRY 195
333 WRONG TECHNIQUE IN DRUG USAGE PROCESS 195
334 ABNORMAL FAECES 194
335 RASH ERYTHEMATOUS 191
336 VIRAL INFECTION 191
337 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 190
338 BURNING SENSATION 189
339 HYPOPNOEA 188
340 DYSPNOEA EXERTIONAL 187
341 BLOOD POTASSIUM DECREASED 186
342 CHOLELITHIASIS 186
343 CYTOMEGALOVIRUS INFECTION 186
344 LETHARGY 186
345 BURNS SECOND DEGREE 185
346 BLOOD PRESSURE SYSTOLIC INCREASED 184
347 RASH MACULAR 184
348 DISABILITY 183
349 FAECES DISCOLOURED 183
350 APHTHOUS ULCER 182
351 HYPOKALAEMIA 182
352 INTESTINAL STENOSIS 182
353 WEIGHT FLUCTUATION 182
354 CATARRH 181
355 ABORTION SPONTANEOUS 180
356 MICTURITION URGENCY 180
357 DRUG EFFECT DECREASED 179
358 EPISTAXIS 179
359 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 179
360 PALLOR 178
361 SERONEGATIVE ARTHRITIS 178
362 TREATMENT NONCOMPLIANCE 178
363 ALANINE AMINOTRANSFERASE INCREASED 177
364 SKIN DISORDER 177
365 INABILITY TO AFFORD MEDICATION 176
366 NEUTROPENIA 176
367 STAPHYLOCOCCAL INFECTION 174
368 NERVOUSNESS 172
369 NEUROPATHY PERIPHERAL 172
370 RESPIRATORY DISORDER 172
371 THROAT IRRITATION 172
372 BALANCE DISORDER 171
373 BOWEL MOVEMENT IRREGULARITY 170
374 CORONARY ARTERY DISEASE 170
375 MEDICATION RESIDUE PRESENT 170
376 DYSPHONIA 168
377 EAR PAIN 168
378 MELAENA 168
379 PERIPHERAL VENOUS DISEASE 167
380 BENIGN PROSTATIC HYPERPLASIA 166
381 THERAPY INTERRUPTED 166
382 GASTROINTESTINAL PAIN 163
383 ULCER 162
384 BLOOD CREATININE INCREASED 161
385 CHROMATURIA 161
386 INSURANCE ISSUE 161
387 SURGERY 161
388 ASPARTATE AMINOTRANSFERASE INCREASED 159
389 LABORATORY TEST ABNORMAL 158
390 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 158
391 UVEITIS 157
392 X-RAY ABNORMAL 157
393 BODY TEMPERATURE DECREASED 156
394 OBESITY 156
395 ANAPHYLACTIC REACTION 155
396 MOUTH ULCERATION 155
397 HYPONATRAEMIA 154
398 LIVE BIRTH 154
399 GASTROINTESTINAL INFECTION 153
400 LEUKOPENIA 153
401 FULL BLOOD COUNT ABNORMAL 152
402 IRON DEFICIENCY ANAEMIA 152
403 PORPHYRIA ACUTE 152
404 SEIZURE 152
405 DEPRESSED MOOD 151
406 HYPOPHAGIA 151
407 CONGENITAL HIATUS HERNIA 150
408 FLUID RETENTION 150
409 RASH PAPULAR 150
410 BACTERIAL INFECTION 148
411 BREATH SOUNDS ABNORMAL 148
412 CYSTITIS 148
413 DRUG EFFECT LESS THAN EXPECTED 147
414 APPENDICITIS 146
415 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 144
416 DISEASE PROGRESSION 144
417 NEOPLASM MALIGNANT 144
418 ANORECTAL DISCOMFORT 141
419 BODY TEMPERATURE INCREASED 141
420 CARDIAC DISORDER 141
421 CONTRAINDICATED PRODUCT ADMINISTERED 141
422 SEPTIC SHOCK 141
423 BLOOD PRESSURE DIASTOLIC DECREASED 137
424 BASAL CELL CARCINOMA 136
425 PRODUCT SUBSTITUTION ISSUE 136
426 RESPIRATORY FAILURE 136
427 BRADYCARDIA 134
428 CLOSTRIDIUM DIFFICILE COLITIS 134
429 PRODUCT RESIDUE PRESENT 134
430 DRUG EFFECT INCOMPLETE 133
431 GASTROENTERITIS 130
432 MYOPERICARDITIS 130
433 INJECTION SITE URTICARIA 129
434 IRON DEFICIENCY 129
435 GASTRITIS 128
436 NEURALGIA 128
437 PREMATURE BABY 128
438 PERICARDIAL EFFUSION 127
439 ENDOMETRIOSIS 126
440 THERAPY PARTIAL RESPONDER 126
441 FEELING COLD 125
442 CARDIAC FAILURE 124
443 DYSURIA 124
444 ALCOHOL POISONING 123
445 FUNGAL INFECTION 123
446 POLLAKIURIA 123
447 HERNIA 122
448 PLATELET COUNT DECREASED 122
449 RECTAL TENESMUS 122
450 SKIN EXFOLIATION 122
451 SNEEZING 122
452 BONE PAIN 121
453 INJECTION SITE RASH 121
454 SKIN LESION 121
455 GASTROENTERITIS VIRAL 120
456 INJECTION SITE HAEMATOMA 119
457 RESPIRATORY TRACT CONGESTION 119
458 TOOTH INFECTION 118
459 HAEMATOCRIT DECREASED 117
460 SPONDYLITIS 117
461 BREAST CANCER 116
462 DRUG TOLERANCE DECREASED 116
463 EYE PAIN 115
464 MALNUTRITION 115
465 MATERNAL EXPOSURE DURING BREAST FEEDING 115
466 ILEUS 114
467 PANIC ATTACK 114
468 HALLUCINATION 112
469 HEPATIC STEATOSIS 112
470 INTESTINAL PERFORATION 112
471 LARGE INTESTINAL STENOSIS 112
472 SUICIDAL IDEATION 111
473 ERYTHEMA NODOSUM 110
474 PHARYNGITIS STREPTOCOCCAL 110
475 LOCALISED INFECTION 109
476 MATERNAL EXPOSURE TIMING UNSPECIFIED 109
477 BLOOD TEST ABNORMAL 108
478 GRIP STRENGTH 107
479 HEPATIC FUNCTION ABNORMAL 107
480 INTENTIONAL DOSE OMISSION 107
481 SKIN DISCOLOURATION 107
482 ABDOMINAL ABSCESS 106
483 ARRHYTHMIA 106
484 CYTOMEGALOVIRUS COLITIS 106
485 LARGE INTESTINAL ULCER 106
486 RED BLOOD CELL COUNT DECREASED 106
487 THERAPY CESSATION 106
488 DRUG SPECIFIC ANTIBODY 104
489 SINUS CONGESTION 104
490 DRUG EXPOSURE DURING PREGNANCY 103
491 OBSTRUCTIVE AIRWAYS DISORDER 103
492 PHARYNGITIS 103
493 INJECTION SITE WARMTH 102
494 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102
495 EMOTIONAL DISTRESS 101
496 END STAGE RENAL DISEASE 101
497 GOUT 101
498 INJECTION SITE PAPULE 101
499 LIP SWELLING 100
500 PRODUCT STORAGE ERROR 100
501 SKIN CANCER 100
502 OCULAR HYPERAEMIA 99
503 PRODUCT DOSE OMISSION 98
504 ANGIOEDEMA 97
505 EATING DISORDER 97
506 LIVER FUNCTION TEST ABNORMAL 97
507 ORAL HERPES 97
508 THERAPEUTIC RESPONSE UNEXPECTED 97
509 TOXICITY TO VARIOUS AGENTS 97
510 EYE SWELLING 96
511 OVERLAP SYNDROME 96
512 RENAL DISORDER 96
513 RESPIRATORY TRACT INFECTION 96
514 THROAT TIGHTNESS 96
515 TRANSAMINASES INCREASED 96
516 ANAL HAEMORRHAGE 95
517 BLOOD ALBUMIN DECREASED 95
518 COLECTOMY 95
519 ENTERITIS 95
520 HYPERLIPIDAEMIA 95
521 BLOOD PRESSURE DIASTOLIC INCREASED 94
522 DRY EYE 94
523 POOR QUALITY SLEEP 94
524 TUBERCULOSIS 94
525 ASCITES 93
526 CHOLANGITIS SCLEROSING 93
527 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 93
528 FEBRILE NEUTROPENIA 93
529 ABNORMAL LOSS OF WEIGHT 92
530 AGITATION 92
531 BLOOD ALKALINE PHOSPHATASE INCREASED 92
532 FEEDING DISORDER 92
533 POST PROCEDURAL COMPLICATION 92
534 ILEAL STENOSIS 91
535 INJECTION SITE MASS 91
536 HAEMATURIA 90
537 PLATELET COUNT INCREASED 90
538 DISTURBANCE IN ATTENTION 89
539 LIMB INJURY 89
540 RENAL FAILURE ACUTE 89
541 SECRETION DISCHARGE 89
542 DRUG LEVEL INCREASED 88
543 INTESTINAL HAEMORRHAGE 88
544 PROSTATE CANCER 88
545 RECTAL ABSCESS 88
546 EOSINOPHILIC PNEUMONIA 87
547 PNEUMONITIS 87
548 DYSCHEZIA 86
549 INFUSION SITE EXTRAVASATION 86
550 LIMB DISCOMFORT 86
551 CARDIAC ARREST 85
552 HAEMOPTYSIS 85
553 IMMUNODEFICIENCY 85
554 SARS-COV-2 TEST POSITIVE 84
555 CARDIAC FAILURE CONGESTIVE 83
556 EPILEPSY 83
557 INTERVERTEBRAL DISC PROTRUSION 83
558 PULMONARY OEDEMA 83
559 HEAD INJURY 82
560 ORAL PAIN 82
561 PRESYNCOPE 82
562 EOSINOPHILIA 81
563 LARGE INTESTINE PERFORATION 81
564 LIPASE INCREASED 81
565 PLEURISY 81
566 PYODERMA GANGRENOSUM 81
567 CRYING 80
568 FURUNCLE 80
569 HYPOTHYROIDISM 80
570 INFUSION SITE PAIN 80
571 PHOTOPHOBIA 80
572 ASPIRATION 79
573 DRUG DEPENDENCE 79
574 DRUG RESISTANCE 79
575 SINUS DISORDER 79
576 SOCIAL PROBLEM 79
577 VITAMIN D DECREASED 79
578 CONVULSION 78
579 GASTRIC ULCER 78
580 INTESTINAL RESECTION 78
581 LEUKOCYTOSIS 78
582 LUNG NEOPLASM MALIGNANT 78
583 MENTAL DISORDER 78
584 METABOLIC ACIDOSIS 78
585 PULMONARY MASS 78
586 AGRANULOCYTOSIS 77
587 HAEMATEMESIS 77
588 HEPATITIS 77
589 HYPOPHOSPHATAEMIA 77
590 PREMATURE LABOUR 77
591 SPINAL FUSION SURGERY 77
592 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 76
593 ANKYLOSING SPONDYLITIS 76
594 BLOOD PRESSURE ABNORMAL 76
595 BLOOD URINE PRESENT 76
596 CONGENITAL ANOMALY 76
597 INJECTION SITE NODULE 76
598 IRRITABILITY 76
599 POLYP 76
600 RIB FRACTURE 76
601 SCAR 76
602 DISORIENTATION 75
603 HYPOACUSIS 75
604 INFLAMMATORY MARKER INCREASED 75
605 JAUNDICE 75
606 LOCAL SWELLING 75
607 TOOTH DISORDER 75
608 DIPLOPIA 74
609 INJECTION SITE EXTRAVASATION 74
610 PRODUCT PHYSICAL ISSUE 74
611 SPEECH DISORDER 74
612 TOOTHACHE 74
613 GASTROINTESTINAL SOUNDS ABNORMAL 73
614 CARDIOVASCULAR DISORDER 72
615 GAMMA-GLUTAMYLTRANSFERASE INCREASED 72
616 HYPERSOMNIA 72
617 KIDNEY INFECTION 72
618 HIP FRACTURE 71
619 MALIGNANT MELANOMA IN SITU 71
620 MALIGNANT MELANOMA STAGE 0 71
621 ORGANISING PNEUMONIA 71
622 ANORECTAL DISORDER 70
623 CANDIDA INFECTION 70
624 CARPAL TUNNEL SYNDROME 70
625 COLON CANCER 70
626 EYE IRRITATION 70
627 SKIN WARM 70
628 TROPONIN INCREASED 70
629 ABDOMINAL ADHESIONS 69
630 MYASTHENIA GRAVIS 69
631 PAIN IN JAW 69
632 PERITONITIS 69
633 PLEURITIC PAIN 69
634 RASH GENERALISED 69
635 TENDERNESS 69
636 URINARY RETENTION 69
637 ABDOMINAL TENDERNESS 68
638 BRAIN FOG 68
639 DEMENTIA 68
640 POSTOPERATIVE WOUND INFECTION 68
641 PUSTULAR PSORIASIS 68
642 SEASONAL ALLERGY 68
643 SKIN ULCER 68
644 VAGINAL HAEMORRHAGE 68
645 BLOOD CALCIUM INCREASED 67
646 BLOOD SODIUM DECREASED 67
647 DIVERTICULUM 67
648 EYE PRURITUS 67
649 FAECES HARD 67
650 FLANK PAIN 67
651 GASTRIC DISORDER 67
652 HYPERPHOSPHATAEMIA 67
653 HYPOALBUMINAEMIA 67
654 LYMPHOMA 67
655 MALIGNANT MELANOMA 67
656 MYOSITIS 67
657 SERUM FERRITIN DECREASED 67
658 HYPOXIA 66
659 ILEOSTOMY 66
660 LACRIMATION INCREASED 66
661 MUSCULOSKELETAL DISCOMFORT 66
662 NEUTROPHIL COUNT INCREASED 66
663 SPUTUM DISCOLOURED 66
664 SUBCUTANEOUS ABSCESS 66
665 ESCHERICHIA INFECTION 65
666 IMMUNOSUPPRESSION 65
667 INCREASED TENDENCY TO BRUISE 65
668 PNEUMOCYSTIS JIROVECII PNEUMONIA 65
669 RASH VESICULAR 65
670 SKIN INFECTION 65
671 VITAMIN D DEFICIENCY 65
672 CLOSTRIDIAL INFECTION 64
673 COLD SWEAT 64
674 DERMATITIS 64
675 ELECTROCARDIOGRAM QT PROLONGED 64
676 HYPOMAGNESAEMIA 64
677 INGUINAL HERNIA 64
678 INTESTINAL FISTULA 64
679 PHOTOSENSITIVITY REACTION 64
680 RECTAL DISCHARGE 64
681 CAESAREAN SECTION 63
682 HEAD DISCOMFORT 63
683 HIATUS HERNIA 63
684 ACCIDENTAL EXPOSURE TO PRODUCT 62
685 BLOOD BILIRUBIN INCREASED 62
686 EYE INFECTION 62
687 GENERAL SYMPTOM 62
688 MOVEMENT DISORDER 62
689 PULMONARY TUBERCULOSIS 62
690 ABSCESS INTESTINAL 61
691 APPETITE DISORDER 61
692 DYSARTHRIA 61
693 PRODUCT USE COMPLAINT 61
694 ROTATOR CUFF SYNDROME 61
695 APHONIA 60
696 BACK DISORDER 60
697 HEPATOTOXICITY 60
698 INCONTINENCE 60
699 INJECTION SITE IRRITATION 60
700 MOOD SWINGS 60
701 PELVIC PAIN 60
702 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 59
703 FOOT FRACTURE 59
704 MASS 59
705 RESPIRATORY SYMPTOM 59
706 SMALL INTESTINAL STENOSIS 59
707 URINARY INCONTINENCE 59
708 CARDIOMYOPATHY 58
709 FEAR OF INJECTION 58
710 PRODUCT PRESCRIBING ERROR 58
711 PRURITUS GENERALISED 58
712 SUICIDE ATTEMPT 58
713 UTERINE LEIOMYOMA 58
714 APHASIA 57
715 BLINDNESS 57
716 COLITIS MICROSCOPIC 57
717 CONJUNCTIVITIS 57
718 EXPIRED PRODUCT ADMINISTERED 57
719 FACE OEDEMA 57
720 GALLBLADDER DISORDER 57
721 LYMPHOCYTE COUNT DECREASED 57
722 MULTIPLE SCLEROSIS 57
723 RESTLESSNESS 57
724 TASTE DISORDER 57
725 TENDONITIS 57
726 ADRENAL INSUFFICIENCY 56
727 EXTRA DOSE ADMINISTERED 56
728 FEAR 56
729 POUCHITIS 56
730 WRIST FRACTURE 56
731 ABNORMAL BEHAVIOUR 55
732 DEVICE RELATED INFECTION 55
733 HAEMORRHOIDAL HAEMORRHAGE 55
734 HEPATIC FAILURE 55
735 MENTAL IMPAIRMENT 55
736 POST PROCEDURAL INFECTION 55
737 PREMATURE DELIVERY 55
738 SLEEP APNOEA SYNDROME 55
739 ARTHROPOD BITE 54
740 CHOLANGITIS 54
741 COGNITIVE DISORDER 54
742 EPSTEIN-BARR VIRUS INFECTION 54
743 EYE DISORDER 54
744 FISTULA DISCHARGE 54
745 GASTROINTESTINAL WALL THICKENING 54
746 SKIN BURNING SENSATION 54
747 SWOLLEN JOINT COUNT 54
748 THINKING ABNORMAL 54
749 ANGINA PECTORIS 53
750 BACTERAEMIA 53
751 BLEPHAROSPASM 53
752 BONE MARROW FAILURE 53
753 BREAST CANCER FEMALE 53
754 CEREBRAL HAEMORRHAGE 53
755 CEREBRAL INFARCTION 53
756 CLOSTRIDIUM TEST POSITIVE 53
757 MYELOSUPPRESSION 53
758 PERIPHERAL COLDNESS 53
759 PROCTITIS ULCERATIVE 53
760 TERMINAL ILEITIS 53
761 TOOTH ABSCESS 53
762 VAGINAL INFECTION 53
763 ANAPHYLACTIC SHOCK 52
764 ENTEROCOLITIS 52
765 OSTEOPENIA 52
766 PARKINSON^S DISEASE 52
767 SHOCK 52
768 SUSPECTED OFF LABEL USE 52
769 VASCULITIS 52
770 CORONARY ARTERY OCCLUSION 51
771 DEAFNESS 51
772 FRUSTRATION TOLERANCE DECREASED 51
773 NEUTROPHIL COUNT DECREASED 51
774 PRODUCT PRESCRIBING ISSUE 51
775 RETCHING 51
776 SKIN IRRITATION 51
777 STREPTOCOCCAL INFECTION 51
778 DISSEMINATED TUBERCULOSIS 50
779 FOOD POISONING 50
780 INJECTION SITE DISCOLOURATION 50
781 MUSCLE ATROPHY 50
782 MUSCULOSKELETAL CHEST PAIN 50
783 OSTEOMYELITIS 50
784 PNEUMONIA BACTERIAL 50
785 PNEUMOTHORAX 50
786 PRODUCT ADMINISTRATION ERROR 50
787 SCAB 50
788 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 50
789 ABASIA 49
790 EAR DISCOMFORT 49
791 ELECTROLYTE IMBALANCE 49
792 EYE INFLAMMATION 49
793 GASTROINTESTINAL MOTILITY DISORDER 49
794 HYPERKALAEMIA 49
795 OROPHARYNGEAL DISCOMFORT 49
796 OVARIAN CYST 49
797 POLYARTHRITIS 49
798 RED CELL DISTRIBUTION WIDTH INCREASED 49
799 SKIN LACERATION 49
800 SLEEP DISORDER THERAPY 49
801 SPINAL FRACTURE 49
802 TONSILLITIS 49
803 ABDOMINAL HERNIA 48
804 ACUTE MYELOID LEUKAEMIA 48
805 ANTACID THERAPY 48
806 ANTICOAGULANT THERAPY 48
807 ATELECTASIS 48
808 BREAST CANCER STAGE II 48
809 CHOLECYSTECTOMY 48
810 CYST 48
811 DYSSTASIA 48
812 GLAUCOMA 48
813 PRODUCT DISTRIBUTION ISSUE 48
814 RESTLESS LEGS SYNDROME 48
815 SJOGREN^S SYNDROME 48
816 AGEUSIA 47
817 ANALGESIC THERAPY 47
818 BACK INJURY 47
819 BODY TEMPERATURE FLUCTUATION 47
820 C-REACTIVE PROTEIN 47
821 EXPOSURE TO SARS-COV-2 47
822 GASTROINTESTINAL OEDEMA 47
823 IMMUNE SYSTEM DISORDER 47
824 INFREQUENT BOWEL MOVEMENTS 47
825 MUSCULOSKELETAL DISORDER 47
826 RESPIRATORY RATE INCREASED 47
827 RHABDOMYOLYSIS 47
828 THIRST 47
829 UPPER LIMB FRACTURE 47
830 CHOLESTASIS 46
831 DRUG ADMINISTRATION ERROR 46
832 ERUCTATION 46
833 PRODUCT DOSE OMISSION IN ERROR 46
834 PYELONEPHRITIS 46
835 AUTOIMMUNE HEPATITIS 45
836 CUSHINGOID 45
837 DERMATITIS ACNEIFORM 45
838 DERMATITIS ATOPIC 45
839 DIVERTICULUM INTESTINAL 45
840 EMOTIONAL DISORDER 45
841 EOSINOPHIL COUNT INCREASED 45
842 HYPOCALCAEMIA 45
843 LIGAMENT SPRAIN 45
844 MIDDLE INSOMNIA 45
845 PARALYSIS 45
846 ULCER HAEMORRHAGE 45
847 ACUTE RESPIRATORY FAILURE 44
848 APPENDICECTOMY 44
849 BLOOD MAGNESIUM DECREASED 44
850 CHOLECYSTITIS 44
851 HAEMORRHAGIC DIATHESIS 44
852 HYPERTHYROIDISM 44
853 INTESTINAL ULCER 44
854 LUNG INFECTION 44
855 NEEDLE ISSUE 44
856 NERVOUS SYSTEM DISORDER 44
857 PAIN OF SKIN 44
858 PNEUMONIA ASPIRATION 44
859 PULMONARY TOXICITY 44
860 BEDRIDDEN 43
861 COELIAC DISEASE 43
862 DERMATITIS ALLERGIC 43
863 DRUG PRESCRIBING ERROR 43
864 ERECTILE DYSFUNCTION 43
865 HYPOGLYCAEMIA 43
866 MULTI-ORGAN FAILURE 43
867 MUSCLE TIGHTNESS 43
868 NERVE COMPRESSION 43
869 NODULE 43
870 RASH MACULO-PAPULAR 43
871 RASH PUSTULAR 43
872 SENSORY DISTURBANCE 43
873 UPPER-AIRWAY COUGH SYNDROME 43
874 LACTOSE INTOLERANCE 42
875 MALABSORPTION 42
876 MENSTRUATION IRREGULAR 42
877 MUCOSAL INFLAMMATION 42
878 RENAL CYST 42
879 RESPIRATORY DISTRESS 42
880 SENSATION OF FOREIGN BODY 42
881 SYMPTOM RECURRENCE 42
882 TONGUE OEDEMA 42
883 ANGER 41
884 BLOOD LACTATE DEHYDROGENASE INCREASED 41
885 BLOOD TRIGLYCERIDES INCREASED 41
886 CONCUSSION 41
887 DRUG THERAPY 41
888 HYPOAESTHESIA ORAL 41
889 NAIL DISORDER 41
890 OESOPHAGITIS 41
891 SPLENOMEGALY 41
892 ABDOMINAL MASS 40
893 ACCIDENT 40
894 ACTIVITIES OF DAILY LIVING IMPAIRED 40
895 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 40
896 ANKLE FRACTURE 40
897 INFUSION SITE SWELLING 40
898 LARGE INTESTINAL HAEMORRHAGE 40
899 MALIGNANT NEOPLASM PROGRESSION 40
900 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 40
901 OSTEONECROSIS 40
902 POST PROCEDURAL HAEMORRHAGE 40
903 PROTEINURIA 40
904 QUALITY OF LIFE DECREASED 40
905 SECONDARY ADRENOCORTICAL INSUFFICIENCY 40
906 SKIN FISSURES 40
907 SQUAMOUS CELL CARCINOMA 40
908 THERAPEUTIC PRODUCT EFFECT DELAYED 40
909 VENTRICULAR FIBRILLATION 40
910 COAGULOPATHY 39
911 CYTOMEGALOVIRUS ENTEROCOLITIS 39
912 DEMYELINATION 39
913 DIFFUSE LARGE B-CELL LYMPHOMA 39
914 DISCOURAGEMENT 39
915 FOOD INTOLERANCE 39
916 HIDRADENITIS 39
917 INCORRECT PRODUCT ADMINISTRATION DURATION 39
918 INCORRECT PRODUCT STORAGE 39
919 INTERNATIONAL NORMALISED RATIO INCREASED 39
920 LIGAMENT RUPTURE 39
921 LYMPHOPENIA 39
922 NERVE INJURY 39
923 SINUS HEADACHE 39
924 UMBILICAL HERNIA 39
925 AORTIC ANEURYSM 38
926 BLOOD CALCIUM DECREASED 38
927 BREAST CANCER STAGE I 38
928 DRUG ABUSE 38
929 ENCEPHALOPATHY 38
930 ENTEROVESICAL FISTULA 38
931 GROWTH RETARDATION 38
932 HEPATOSPLENIC T-CELL LYMPHOMA 38
933 INJECTION SITE INDURATION 38
934 INTRAOCULAR PRESSURE INCREASED 38
935 MENISCUS INJURY 38
936 MOOD ALTERED 38
937 MUSCLE TWITCHING 38
938 OCULAR DISCOMFORT 38
939 SKIN PAPILLOMA 38
940 SUBILEUS 38
941 WITHDRAWAL SYNDROME 38
942 ACUTE RESPIRATORY DISTRESS SYNDROME 37
943 DENTAL CARIES 37
944 DISSEMINATED INTRAVASCULAR COAGULATION 37
945 DYSKINESIA 37
946 POOR QUALITY PRODUCT ADMINISTERED 37
947 RENAL PAIN 37
948 VISUAL ACUITY REDUCED 37
949 VITAMIN B12 DECREASED 37
950 ANTINUCLEAR ANTIBODY POSITIVE 36
951 ARTHRITIS INFECTIVE 36
952 BLADDER DISORDER 36
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 36
954 CYANOSIS 36
955 FOETAL GROWTH RESTRICTION 36
956 GESTATIONAL DIABETES 36
957 INJURY ASSOCIATED WITH DEVICE 36
958 LARGE INTESTINAL OBSTRUCTION 36
959 LUNG INFILTRATION 36
960 OBSTRUCTION 36
961 PAPULE 36
962 RENAL INJURY 36
963 TAKAYASU^S ARTERITIS 36
964 VEIN RUPTURE 36
965 ACUTE MYOCARDIAL INFARCTION 35
966 CARDIOGENIC SHOCK 35
967 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35
968 ENTEROCUTANEOUS FISTULA 35
969 FACIAL PAIN 35
970 FAECAL CALPROTECTIN ABNORMAL 35
971 FAECAL INCONTINENCE 35
972 HYDRONEPHROSIS 35
973 INJECTION SITE VESICLES 35
974 INTESTINAL ANASTOMOSIS 35
975 LOWER GASTROINTESTINAL HAEMORRHAGE 35
976 PARANASAL SINUS DISCOMFORT 35
977 PRODUCT ODOUR ABNORMAL 35
978 PULMONARY THROMBOSIS 35
979 SERUM SICKNESS 35
980 TYPE IV HYPERSENSITIVITY REACTION 35
981 CHOKING 34
982 DEPRESSED LEVEL OF CONSCIOUSNESS 34
983 DERMATITIS CONTACT 34
984 DYSLIPIDAEMIA 34
985 FEAR OF DISEASE 34
986 HYPERGLYCAEMIA 34
987 INCORRECT ROUTE OF DRUG ADMINISTRATION 34
988 INTERNAL HAEMORRHAGE 34
989 LOW BIRTH WEIGHT BABY 34
990 MACULOPATHY 34
991 MUSCLE STRAIN 34
992 PERIRECTAL ABSCESS 34
993 PSYCHOTIC DISORDER 34
994 TOOTH FRACTURE 34
995 VITAMIN B12 DEFICIENCY 34
996 DECUBITUS ULCER 33
997 GASTROINTESTINAL BACTERIAL INFECTION 33
998 GENERALISED OEDEMA 33
999 HAEMATOMA 33